.jpg)
.png)
2023 Fall LipidSpin
This issue is sponsored by the Northeast and Southeast Lipid Associations
This page was last updated: Oct 17, 2023
Medication Adherence
Article By:
Cindy Nee, PharmD
Grady Health System
Atlanta, GA
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Grady Health System
Atlanta, GA
Medical nutrition therapy (MNT) by trained registered dietitian nutritionists (RDN) is an integral part of a multidisciplinary health care team. Research has shown that this therapy is clinically beneficial and cost effective.1,2,3 For patients with cardiometabolic disease, in particular diabetes and obesity, it is essential for optimizing quality of life and prevention of manifest cardiovascular disease.
Article By:
Merle Myerson, MD, EdD, FACC, FNLA
Etna, NH
Wayne Warren, MD, FNLA
Internal Medicine
Northeast Medical Group
Yale New Haven Health
Sarah Miller, RD
Northwell Health
New York, NY
Anna Biggins, MPH, RDN, LD
Georgia Heart Institute
Gainesville, GA
Introduction
Article By:
Rachel Tobin, MD
Cardiology Fellow
Emory University
Atlanta, Georgia
Gina Lundberg, MD, FACC, FAHA
Clinical Director Emory Women’s Heart Center
Professor of Medicine
Division of Cardiology
Emory University School of Medicine
Atlanta, GA
Definitions
Article By:
Dimitra Bantouna, MD
Endocringology, Diabetes, and Metabolism Clinics
Private Practice
Patras, Greece
Rodis D. Paparodis, MD, FNLA
Endocringology, Diabetes, and Metabolism Clinics
Private Practice
Patras, Greece
Center for Diabetes and Endocrine Research
University of Toledo College of Medicine and Life Sciences
Toledo, OH, USA
Dr. Google, referencing ACC, tells us that cardiometabolic disorders represent a cluster of interrelated risk factors, primarily hypertension, elevated fasting blood sugar, dyslipidemia, abdominal obesity, and elevated triglycerides.
Examples of the disease include heart attack, stroke, diabetes, insulin resistance, nonalcoholic fatty liver disease, and chronic kidney disease.
Article By:
Jan McAlister, DNP, CLS, FNLA
President, Southeast Lipid Association
Atlanta, GA
Living in New York City, specifically the Upper East Side (UES), the congestion of food delivery workers 24/7 has become the norm. There are an estimated 65,000 delivery workers to meet the needs of the continuous rise of the fast-food franchise in NYC. You may recall from Sex and the City that Carrie Bradshaw used her oven as extra closet space; this is not far-fetched from the truth of upper east side culture.
Article By:
Roda Plakogiannis, PharmD, BCPS, BCACP, CLS, FNLA
President, Northeast Lipid Association
New York, NY
Cardiovascular disease (CVD) remains the #1 killer of American men and women. Following recognition of the large gap between deaths of women as compared to men in the year 2000, there was subsequent intense focus on prevention of CVD in women. Following the launch of campaigns such as Go Red by the American Heart Association and Heart Truth by the National Heart, Lung, and Blood Institute, CVD deaths sharply declined in both women and men.
Article By:
Lynne T. Braun, PhD, CNP, CLS, FNLA
LipidSpin Co-Editor, National Lipid Association
Chicago, IL
Hello NLA members, I hope everyone had a wonderful summer. As our long, warm days move into cool fall nights, the NLA continues to charge ahead, expanding educational opportunities for providers to combat the rise of cardiovascular disease.
Article By:
Daniel E. Soffer, MD, FNLA
President, National Lipid Association
Philadelphia, PA
Last Updated: Thursday, 13-Jul-2023 14:45:00 EDT
Novartis received FDA approval for a label update that will allow for use of Leqvio ® (inclisiran) in certain patients at high risk of cardiovascular (CV) disease. This broader population allows for earlier Leqvio treatment in patients with elevated low-density lipoprotein cholesterol (LDL-C) and CV risk factors, such as diabetes and hypertension, who are at increased risk of atherosclerotic cardiovascular disease (ASCVD), beyond the previously approved ASCVD and heterozygous familial hypercholesterolemia (HeFH) patient population.